enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Ciclosporin - Wikipedia

   en.wikipedia.org/wiki/Ciclosporin

   Generic ciclosporin preparations have been marketed under various brand names, including Cicloral (by Sandoz/Hexal), Gengraf (by Abbott) and Deximune (by Dexcel Pharma). Since 2002, a topical emulsion of ciclosporin for treating inflammation caused by keratoconjunctivitis sicca (dry eye syndrome) has been marketed under the brand name Restasis. [9]

3. The St. Regis Mohawk Tribe and Restasis patent - Wikipedia

   en.wikipedia.org/wiki/The_St._Regis_Mohawk_Tribe...

   Saint Regis Mohawk Tribe v. Mylan Pharms. Inc., 896 F.3d 1322 (Fed. Cir. 2018) is a United States Patent case, decided by the CAFC, deciding whether or not indigenous tribes' sovereign immunity extended to patent lawsuits. In September 2017, the American pharmaceutical company Allergan agreed to transfer six pharmaceutical patents for the ...

4. Lifitegrast - Wikipedia

   en.wikipedia.org/wiki/Lifitegrast

   Lifitegrast, sold under the brand name Xiidra ( / ˈzaɪdrə / [2] ), is a medication for the treatment of signs and symptoms of dry eye, a syndrome called keratoconjunctivitis sicca. Lifitegrast reduces inflammation by inhibiting inflammatory cell binding. [3] It is often used in conjunction with ciclosporin (Ikervis, Restasis, or Cequa) for ...

5. Netarsudil - Wikipedia

   en.wikipedia.org/wiki/Netarsudil

   Netarsudil. Netarsudil, sold under the brand name Rhopressa among others, is a medication for the treatment of glaucoma. [1] [2] [3] In the United States, in December 2017, the Food and Drug Administration (FDA) approved a 0.02% ophthalmic solution for the lowering of elevated intraocular pressure in people with open-angle glaucoma or ocular ...

6. Do You Qualify for Any of August’s Class-Action Settlements?

   www.aol.com/qualify-august-class-action...

   Consumers could benefit from numerous settlements with claim deadlines in August. The settlements resolve claims from data breaches, defective products, privacy issues and more. If you’re ...

7. Viatris (VTRS) Gets FDA Nod for Generic Drug in Dry Eye ... - AOL

   www.aol.com/news/viatris-vtrs-gets-fda-nod...

   Viatris' (VTRS) subsidiary is the first to receive approval from the FDA to market a generic version of AbbVie's Restasis for the treatment of dry eye disease.